Femara 2.5 mg tablet

Description

Femara 2.5mg tablets contain the active ingredient letrozole,

a potent non-steroidal aromatase inhibitor used Femara 2.5mg tablets ONLINE primarily to treat hormone receptor-positive breast.

cancer in postmenopausal Femara 2.5mg tablets PRICE women. It works by significantly lowering BUY Femara 2.5mg tabletsestrogen levels, thereby slowing or stopping the growth of cancer cells that rely on estrogen to grow.

Indications for Breast Cancer Treatment: First-line and adjuvant treatment of hormone-dependent early and advanced breast cancer in postmenopausal women. Extended Adjuvant Treatment: Treatment of breast cancer in women after 5 years of tamoxifen treatment. Off-label use for fertility purposes: Treatment of infertility in premenopausal women.

Femara acts by inhibition of enzyme aromatase, blocking androgens’ conversion to estrogens.Due to reduced estrogen levels, the drug deprives tumors of hormones necessary for their development. Active substance: letrozole 2.5mg per film-coated tablet. Other ingredients: lactose monohydrate 61.5 mg per film-coated tablet.

One tablet of 2.5 mg administered orally once a day. Way of administration: Tablets can be used with/without food; swallowing tablets whole, drinking glass of water. Mode of administration: It is recommended to take Femara at the same time each day for the sake of uniform medicine concentration.

Letrozole is an aromatase inhibitor drug that is used to treat breast cancer in postmenopausal women. Letrozole (CGS 20267) is an oral type II aromatase inhibitor, which was introduced in the literature in 1990.